Gyros AB has launched a new website (www.gyros.com).
The re-designed site features application-focused information demonstrating the value of the Gyros platform in biopharma R&D, to improve resource use, immunoassay quality, and turnaround times.
The Gyros nanoliter-scale immunoassay platform utilizes microfluidic technology to automate highly controlled immunoassays, providing high quality, traceable data to help meet regulatory standards.
Assays developed on the Gyros platform transfer easily between sites and from development to regulated environments.
The platform is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows.
The new Gyros website presents enhanced content including application note downloads, webinars featuring customer presentations, and product information sheets.
Gyros will host a series of seminars in Europe and the US during 2013, for customers and researchers working in the biopharma industry.
Recordings of presentations give at past seminars are available on the website.